Exploring the Role of Soluble Factors Associated with Immune Regulatory Properties of Mesenchymal Stem Cells

被引:120
作者
Bassi, Enio Jose [1 ]
de Almeida, Danilo Candido [2 ]
Mendes Moraes-Vieira, Pedro Manoel [1 ]
Saraiva Camara, Niels Olsen [1 ]
机构
[1] Univ Sao Paulo, Inst Biomed Sci 4, Dept Immunol, Lab Transplantat Immunobiol, BR-05508000 Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Div Nephrol, Dept Med, BR-04039000 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Mesenchymal stem cells; Immune regulation; Immune system; Soluble factors; Immunotherapy; Inflammation; LEUKEMIA INHIBITORY FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; THERAPY POSITION STATEMENT; T-LYMPHOCYTE PROLIFERATION; ANTIGEN-PRESENTING CELLS; GROWTH-FACTOR-BETA; STROMAL CELLS; NITRIC-OXIDE; DENDRITIC CELLS; UMBILICAL-CORD;
D O I
10.1007/s12015-011-9311-1
中图分类号
Q813 [细胞工程];
学科分类号
100113 [医学细胞生物学];
摘要
Mesenchymal stem cells (MSCs) are characterized as multipotent stromal cells with the capacity for both self-renewal and differentiation into mesodermal cell lineages. MSCs also have a fibroblast-like phenotype and can be isolated from several tissues. In recent years, researchers have found that MSCs secrete several soluble factors that exert immunosuppressive effects by modulating both innate (macrophages, dendritic and NK cells) and adaptive (B cells and CD4+ and CD8+ T cells) immune responses. This review summarizes the principal trophic factors that are related to immune regulation and secreted by MSCs under both autoimmune and inflammatory conditions. The understanding of mechanisms that regulate immunity in MSCs field is important for their future use as a novel cellular-based immunotherapy with clinical applications in several diseases.
引用
收藏
页码:329 / 342
页数:14
相关论文
共 114 条
[1]
Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[2]
Leukemia inhibitory factor and human embryo implantation [J].
Aghajanova, L .
UTERUS AND HUMAN REPRODUCTION, 2004, 1034 :176-183
[3]
Human Bone Marrow-Derived Mesenchymal Stem Cells Induce Th2-Polarized Immune Response and Promote Endogenous Repair in Animal Models of Multiple Sclerosis [J].
Bai, Lianhua ;
Lennon, Donald P. ;
Eaton, Valerie ;
Maier, Kari ;
Caplan, Arnold I. ;
Miller, Stephen D. ;
Miller, Robert H. .
GLIA, 2009, 57 (11) :1192-1203
[4]
Bassi Enio Jose, 2011, World J Stem Cells, V3, P1, DOI 10.4252/wjsc.v3.i1.1
[5]
INDUCTION OF INDOLEAMINE DIOXYGENASE BY INTERFERON IN MICE - A STUDY WITH DIFFERENT RECOMBINANT INTERFERONS AND VARIOUS CYTOKINES [J].
BIANCHI, M ;
BERTINI, R ;
GHEZZI, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 152 (01) :237-242
[6]
Bingisser RM, 1998, J IMMUNOL, V160, P5729
[7]
Blancou P, 2011, METHODS MOL BIOL, V677, P247, DOI 10.1007/978-1-60761-869-0_18
[8]
MACROPHAGE DEACTIVATION BY INTERLEUKIN-10 [J].
BOGDAN, C ;
VODOVOTZ, Y ;
NATHAN, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1549-1555
[9]
Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling [J].
Boniface, Katia ;
Bak-Jensen, Kristian S. ;
Li, Ying ;
Blumenschein, Wendy M. ;
McGeachy, Mandy J. ;
McClanahan, Terrill K. ;
McKenzie, Brent S. ;
Kastelein, Robert A. ;
Cua, Daniel J. ;
Malefyt, Rene de Waal .
JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (03) :535-548
[10]
Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction [J].
Burchfield, Jana S. ;
Iwasaki, Masayoshi ;
Koyanagi, Masamichi ;
Urbich, Carmen ;
Rosenthal, Nadia ;
Zeiher, Andreas M. ;
Dimmeler, Stefanie .
CIRCULATION RESEARCH, 2008, 103 (02) :203-211